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Epidermal Cell-Induced Generation of Cytotoxic T-Lymphocyte 
Responses Against Alloantigens or TNP-Modified Syngeneic Cells: 
Requirement for !a-Positive Langerhans Cells* 
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The role of epidermal cells (EC) in the activation ofT-
cell proliferation is well established. In this study we 
asked whether EC can provide a stimulus resulting in 
the generation of genetically restricted T-cell cytotox-
icity. For this purpose, C57Bl/6 or C3H/He highly pur-
ified, accessory cell-depleted responder splenic T lym-
phocytes, were stimulated in· 5-day cell-mediated cyto-
toxicity cultures with mitomycin C-treated allogeneic 
or trinitrophenyl (TNP)-modified syngeneic EC, or, for 
control purposes, with unfractionated spleen cells (SC). 
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Abbreviations: 
C': complement 
CML: cell-mediated lympholysis 
CTL: cytotoxic C lymphocyte(s) 
EC: epidermal cell (s) 
FCS: fetal calf serum 
FITC: fluorescein isothiocyanate 
LC: Langerhans cell(s) 
NMS: normal mouse serum 
SC: spleen cell(s) 
TNBS: 2,4,6-trinitrobenzenesulfonic acid 
TNP: trinitrophenyl 
Untreated and complement (C')-treated EC induced 
strong cytotoxic T lymphocyte (CTL) activity in highly 
purified allogeneic T cells and, in analogy, TNP-modi-
fied EC led to the generation of TNP-self CTL, as tested 
in 4 -h 51 Cr release assays against allogeneic or TNP-
modified syngeneic EC or SC targets. These cytotoxic 
responses were comparable in magnitude to those seen 
with allogeneic or TNP-modified syngeneic SC stimu-
lators. In contrast, alloreactive or TNP-self CTL re-
sponses were not generated when stimulating EC were 
depleted of Langer hans cells by pretreatment with anti-
Ia monoclonal antibodies plus C' or, for control .pur-
poses, when highly purified T-cell stimulators were 
used. 
These results demonstrate that EC induce the gener-
ation of alloreactive and TNP-self CTL in the absence 
of Ia-positive splenic accessory cells and that !a-bearing 
Langer hans cell are required for this process to occur. 
In the recent past it has been clearly shown that epidermal 
cells (EC), consisting of keratinocytes, melanocytes, and Lan-
gerhans cells (LC), can initiate cutaneous immune reactions. 
This is particularly true for LC. These dendritic cells comprise 
a small population (3-8% ) of all EC, originate from a bone 
marrow-derived precursor, bear Fc-IgG and C3b receptor sites, 
synthesize Ia antigens, and are critically needed for EC-induced 
antigen-specific, allogeneic and mitogenic (L. A. Sting!, unpub-
lished observation) T -cell proliferative responses (reviewed in 
[1]). Furthermore, murine EC induce the generation of cyto-
toxic T lymphocytes (CTL). This has been reported for allo-
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reactive CTL responses by Steinmuller et al [2,3] and recently 
we were able to show t hat hapten-modified EC allow hapten-
self primed spleen cells (SC) to mature into hapten-self CTL 
(4] . Since in these previous experiments [2-4] EC-induced CTL 
responses were generated in t he presence of !a-bearing splenic 
accessory cells [5,6], it remained unclear whether EC served 
only to provide a source of antigenic determinants or whether 
t hey alone were actively capable of inducing primary allogeneic 
and hapten-self CTL responses. In this report we demonstrate 
t hat EC induce the maturation of highly purified T lymphocytes 
into CTL reactive against alloant igens or trinit rophenyl 
(TNP)-modified syngeneic cells, and that Ia antigen-bearing 
LC are critical in this process. 
MATERIALS AND METHODS 
Animals 
C57Bl/6 (H -2h; abbreviated B6) , C3H/ He (H -2"; abbreviated C3H) 
a nd BALB/c (H -2d ) mice of either sex were obtained from t he Zent ra-
Ja nstalt fu r Versuchstiere, Hannover, F.R.G., and were used at 6- 12 
weeks of age. In any given experiment, only mice of one sex were used. 
Antisera 
An anti-1-Ah monoclonal antibody (25-9-17S; complement (C')-de-
pendent cytotoxic ant i-1-A t ite r 1:256 on H-2" [7] was a generous gift 
of Dr. David Sachs (N .C.!., N.I.H., Bethesda, Maryland); a monoclonal 
JgG 2b anti-mouse Jak [2] antibody was purchased from Becton Dick-
inson, Sunnyvale, California; and MAS 034 rat lgG antibody against 
mouse macrophage Clone M1/70.15, Sera- lab, Crawley Down, Sussex, 
E ngland, was used. 
T Cells 
Dissociated SC were suspended in medium RPMI 1640 (GIBCO, 
Grand Island, New York) conta ining 10% heat inactivated feta l calf 
serum (FCS, GIBCO) and were freed from adherent cells by passage 
over nylon wool (FT 242, Fenwal Labs. , Morton Grove, Illinois) col-
umns, using a slight modification of the procedure described by 
Schwartz eta! [8]. Nonadherent cells were elu ted, washed, and t hen 
applied to Sephadex G-10 (Pharrnacia Fine Chemicals, Uppsala, Swe-
den) columns, and incubated fo r 30 min at 37"C, to remove residual 
adherent cells [9] . For complete depletion of !a-bearing cells, elu ted, 
column-purified T cells (1 x 107 / ml) were incubated for 30 min at 4 "C 
with RPMI 1640, conta ining either anti-1-A'' monoclonal antibody at a 
final dilution of 1:256 or antimouse Iak [2] at a final dilut ion of 1:100. 
Lowtox rabbit C' (Cedarlane Labs. Ltd., Ontario, Canada) was added 
to a final dilut ion of 1:10 a nd t he incubation was cont inued for 30 min 
at 37"C. Cells were then extensively washed and resuspended to appro-
priate viable cell numbers, as determined by t rypan blue exclusion, for 
furth er procedures. 
Epidermal Cells 
Single cell suspension of EC were prepared from C3H a nd 86 ear 
skin as previously described [10] and were found to be devoid of 
macrophages as determined by immunofluorescence, using a rat lgG 
antimacrophage ant ibody. To deplete !a -bearing cells, C3H EC (1 X 
107 viable ce lls/ml) were treated with ant i-Iak [2] or, for cont rol 
purposes, wit h heat- inactivated normal mouse serum (NMS), and C' 
as described elsewhere [10]. 
Hapten-Modification of Epidermal Cells and Spleen Cells 
For TNP modification, extensively washed unt reated, C' -t reated, 
anti -Ia + C' -treated EC and SC or highly purified splenic T cells (1 X 
107 cells/ml) were inbuated with 2,4,5-trini t robenzenesulfonic acid 
(TNBS, Sigma Chemical Co., St. Louis, Missouri) at a concentration 
of 5 mM (pH 7.2) for 10 min at 37"C [11 ,12]. For modification with 
fluorescein isothiocyanate (FITC, Sigma), the same number of cells 
was incubated wit h FITC 200 J.Lg/ml (pH 9) for 15 min at 37"C 
[11 ,12]. Following incubation, cells were extensively washed and resus-
pended in supplemented RPM! 1640. 
Primary In Vitro Generation of CTL 
Priming cu ltures were perfo rmed in 16 rum-diameter t issue cul ture 
plates (Linbro, Flow Labs., Bonn , F.R.G.) as previously described 
[4,11]. Briefly , highly purified splenic responder T cells (3- 5 x 106 
cells/well) were cocultured with various stimulator cells-which had 
been treated for 30 min wit h mitomycin C (25 J.Lg/ml; Sigma) - at. a 
responder:stimulat.o r ratio of 10:1 in 2 ml of cult ure medium for 5 days 
at 37"C in 95% a ir/5 % C02• Cul ture medium RPMI 1640 (GIBCO) was 
prepared to contain a fina l concentration of 10% screened heat-inac-
t ivated FCS (GIBCO), 5 X 10- 5 M 2-mercaptoetha nol, 20 mM L-
glutamine (GIBCO) , 1 J.LM sodiu m pyruvate, 0.1 mM nonessential amino 
ac ids (M. A. Bioproducts, Walkersville, Maryla nd) , and 50 J.Lg/ ml 
gentamycin (Flow). 
Chromium Release Assay 
The cytotoxic potent ial of primed responder cells was determined in 
4-hr 51Cr release assays as descr ibed previously [4,11]. Briefly, effector 
cells were harvested, washed, resuspended to t he desired concentration 
of viable cells in medium RPMI 1640 containing 10% FCS, a nd added 
to round-bottom microtiter wells (Linbro, F low). Concanavalin A 
(Pharmacia, 1.6 J.Lg/ml medium)-stimulated (for 48 h) SC or fres hly 
prepared EC were used as target cells and were chromium labeled by 
incubating with Na25 'Cr0 4 (New England Nuclear, Boston, Massachu -
setts) at 0.1 mCi/ ml/107 cells in medium, conta ining 10% FCS for 2 h 
at 37"C. Cells to be haptenated were washed once and treated as 
described above. After 3 washes in medium containing 10% FCS, 
appropriate numbers of target cells (10'/ well ) were added to t he various 
effector cells to give a final volume of 200 11!. P lates were cent rifuged 
for 4 min at 300 rpm a nd incubated for 4 h at 37"C in a 95% ai r/5% 
C02 atmosphere. After t he incubat ion the plates were cent ri fuged for 
5 min at 800 rpm, the supernatants were collec ted with the T ite rtek 
Supernatant Collecting System (Flow) and coun ted in a Gamma 4000 
counte r (Bec kman Instruments Inc., Irvine, California). T he percent-
age cytotoxicity was calculated based on tr iplicate cultures as fo llows: 
. . Exp,pm - Medium,pm 
Percent specific lys is = M M d. x 100 
8Xcpm - e IUlTi cpm 
Expcpm were t he counts re leased from wells containing effector cells 
plus 51Cr targets. Mediumcpm (spontaneous release) were t he counts 
released by 5 1Cr ta rget cells in medium alone and neve r exceeded 28% 
of t he Maxcpm· Maxcpm (maximum lysis) were determined by incubating 
5 1Cr-labeled ta rgets in a 5% solut ion of Triton-X in distilled water. 
RESULTS 
EC Induce the Generation of Alloreactiue CTL in Highly 
Purified T Cells 
A requirement for investigating the capacity of EC to induce 
t he generation of a lloreactive CTL in the absence of splenic 
accessory cells, was to establish the critical role of t hese !a-
positive accessory cells in conventional allogeneic SC cell -
mediated lympholysis (CML) cultures. The finding that C3H 
stimulator T cells failed to generate a lloreactive CTL activity 
in B6 T lymphocytes (Fig 1) confirms prev ious reports [6] and 
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EFFECTOR : TARGET CELL RATIO 
F IG 1. EC-induced allogeneic CTL response: effect of anti-la + C' 
t reatment. Adherence column -purified, ant i-Ia + C' -treated C57Bl/ 6 
T lymphocytes (3 x 106 ) stimulated wit h 3 x 105 allogeneic C3H / He 
cells. Stimulator cells: unfractionated SC (e---e); column purified, 
ant i-Ia + C' -treated T cells (0----0); unt reated EC (.&--.&); C'-
t reated EC (A.- ---A.); anti-Ia + C' -treated EC (£>----£>) . Effector cells 
were assayed against allogeneic C3H/ He SC ta rgets (spontaneous re-
lease 18.2%); percent specific lysis of cont rol cultures (i.e., stimulation 
with syngeneic SC or EC < 2.3%); percent specific lysis on syngeneic 
C57Bl/6 SC ta rgets< 1.8%, (spontaneous release 18.6%). 
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indicates that the purification procedure used removes cell 
types of splenic origin necessary for t he induction of alloreac-
tive CTL in vitro. In contrast, strong allogeneic CTL responses 
were readily observed in highly purified B6 T cells after stim-
ulation with unfractio nated allogeneic C3H SC (Fig 1), dem-
onstrating that the purification procedure did not inhibit t he 
ability ofT cells to develop into functiona lly active CTL. 
To address the question of whether EC induce alloreactive 
CTL in T lymphocytes freed from any functionally detectable 
splenic accessory ce lls, highly purified B6 T cells were stimu-
lated with allogeneic C3H EC. In a series of 3 experiments, 
C3H EC induced considerable CTL responses directed against 
allogeneic C3H SC, but not against syngeneic B6 SC target. A 
representative experiment is depicted in Fig 1. In addit ion , 
when SC targets were replaced by EC targets, EC- induced CTL 
alloreactivity was equally well detectable (data not shown). 
These experiments demonstrate t hat EC by t hemselves can 
induce the generation of alloreactive CTL in column-purified, 
accessory cell-depleted T cells. 
/a-Positive LC Are Critical for the EC-lnduced Generation of 
Alloreactiue CTL 
Since the epidermis is a heterogenous t issue, we sought to 
determine the importance of its different cellular components 
in CTL induction. Considering the critical role of !a-positive 
splen ic adherent cells in SC-CML cultures [6], it seemed rea-
sonable to investigate t he role of !a-positive LC in the genera-
t ion of EC-induced alloreactive CTL. At t he present time, no 
re liable method exists to physically separate murine LC from 
other EC. We t herefore performed killing experiments in which 
C3H EC were pretreated with specific anti-Iak monoclonal 
antibody plus C' - or as a control, normal mouse serum and 
C' - and were used as stimulator cells for highly purified allo-
geneic B6 T cell responders. Treatment of EC with C' a lone 
decreased viability from an original 80- 90% to approximately 
50- 60%. However, as seen in Fig 1, C' treatment did not 
diminish the stimulatory capacity of EC in the generation of 
alloreactive CTL. In contrast, no alloreactive CTL response 
was generated in highly purified B6 T cells when stimulating 
C3H EC had been pretreated with anti-Iak monoclonal antibody 
plus C' (Fig 1). In light ofthe fact t hat anti-Ia plus C' treatment 
did not further decrease the viability of EC as compared to C' 
treatment alone, these results demonstrate that t he capacity of 
EC to induce alloreactive CTL responses is critically dependent 
upon the presence of only a small number of !a-positive EC, 
presumably LC. Surprisingly, anti Iak plus C' -treated C3H EC 
also failed - although not completely- to stimulate t he gener-
ation of CTL responses in unfractionated, accesso ry cell -con-
taining, allogeneic B6 responder SC, whereas highly purified 
C3H T cells were sufficient for CTL generation (Fig 2) . 
LC Requirement for the Induction of Primary TNP-Self CTL 
Responses by TNP-Modified EC 
Considering t he preeminent role of the epidermis in main-
taining the homeostasis between t he host and its environment 
we sought to determine whether EC are capable of init iating 
cellular effector mechanisms aga inst offending environmental 
immunogens such as chemically highly reactive haptens. 
Coculture of column -purified, anti-Ia plus C' -treated un-
primed C3H T cells with untreated or C' -treated TNP-modified 
syngeneic EC or, for control purposes, TNP-modified SC re-
su lted in the development of strong CTL activity when assayed 
against both syngeneic TNP-moditied C3H SC and EC targets 
(Fig 3) but not when tested against unmodified or FITC-
modified syngeneic, or TNP-modified allogeneic (BALB/c) tar-
gets. In sharp contrast, ant i-Ia plus C' -treated (i.e., LC-de-
pleted) EC were ineffective as stimulators in t he generation of 
TNP-self CTL activi ty as were TNP-modified highly purified 
T ce lls (Fig 3). These results demonstrate that TNP-modified 
EC induce primary TNP-self CTL responses in the absence of 
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EFFECTOR: TARGET CELL RATIO 
FIG 2. EC-induced allogeneic CTL response in unfractionated re-
sponder SC: effect of anti- Ia + C' t reatment. On fractionated C57Bl/6 
SC (3 x 106 ) were stimulated with 3 X 105 allogeneic C3H/He cells. 
Stimulator ce lls: unfractionated SC (e-e), column -purilied, anti Ia 
+ C' -treated T cells (0----0) , untreated EC (&--&); C' -treated EC 
(&-- --&) ant i Ia + C' -treated EC (6----6). Effector cells were assayed 
against allogeneic C3H/He SC ta rgets and data are expressed as 
ar ithmetic mean of the individual values of 6 different experiments. 
SEM never exceed 9.8% and have been om itted to enable clearer 
comparison of t he experimental groups. Percent specific lysis of control 
cul tures (i.e. , stimulation with syngeneic SC or EC < 8.5). 
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EFFECTOR :TARGET CELL RATIO 
FIG 3. EC-induced primary TNP-self CTL response: abrogation by 
a nti-Ia + C' t reatment. Adherence colu mn-purilied anti-Ia + C' -
t reated C3H/He T lymphocytes (5 X 10") were cocul tured with 5 X 105 
syngeneic TNP-moditied stimulator ce lls: unfractionated SC 
(e-e), column-purified anti-la + C' -treated T cells (0--0), C'-
treated EC (&--&),and an t i-la + C' -treated EC (6--6). Effector 
cells were assayed against (A) syngeneic TNP-SC targets (spontaneous 
release 27. 7%) and (B) syngeneic TNP-EC targets (spontaneous release 
23.6%); percent specific lysis of control cultures (i.e., stimu lation with 
unmodified C3H SC or EC < 15.2%); percent specific lys is on unmod-
ified targets: SC < 3.18%, EC < 2.3% . (One of 3 representative exper-
iments). 
splenic accessory cells and point toward the crucial role of !a-
bearing LC in t his process. 
DISCUSSION 
The fina l outcome of an in vivo immune response is princi-
pally determined by three major factors, i.e. t he immunocom-
petence of the host, the amount of antigen administered, and 
particularly, t he route of ant igen administration. It is well 
established that epicutaneous [13] or subcutaneous [14] admin-
istration of immunogens leads to the delivery of potent sensi -
tizing signals, whereas intravenous administration frequently 
results in specific immunosuppression [14-16]. It has been 
hypothesized that this phenomenon depends upon the presence 
of a population of potent ant igen-presenting cells expressing I-
A and 1-E/C determinants within the skin which, after having 
encountered the relevant antigen, provide a strong sens itizing 
signal [17,18]. Indeed, !a-bearing epidermal LC are critically 
needed for the activation of EC-induced, antigen-specific and 
allogeneic T-cell proliferation [1 ]. However, the immunologic 
consequences of this EC-induced T-cell proliferation, i.e., t he 
effecto r mechanisms generated, are still unknown. We were 
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t h erefore interested in t he question of whether EC a re capable 
of inducing a T -cell effector mechanism affecting t he skin, i.e., 
t h e ge neration of a llogeneic and hapte n-self CTL. T he possible 
s igni ficance of CTL resp onses d irected against skin targets can 
be inferred from expe riments which demo nstrated (a) t hat 
a lloreactive CT L can lead to EC lysis in vitro [2,3 ), (b) t hat 
a dop t ively transferred CTL expanded in T -cell growth factor 
can induce accelerated skin graft rejection in vit ro [19), and 
f ina lly, (c) t hat hapten -self CT L can lyse syngeneic hapten -
modified EC targets [4,12); t he latter event may be operative 
in a variety of skin d iseases cha racterized by derm al lympho-
cytic infil t rates and EC destruction , e.g., a llergic contact hy-
persen sit ivity [ 4,12]. 
In order to study t he efficacy of EC to generate CTL we fe lt 
it necessary to emp loy a system in which t he stimulating sign al 
is restricted to t he EC, t hus not inf1uenced by any other cell 
type capable of ini t iating an immune respon se, such as splenic 
accessory cells (5,6). This was ac hieved by using column-
p urified , an t i-Ia plus C' -treated responder T cells which were 
una ble to mature into functiona l active CTL when stimulated 
w it h highly purified allogeneic or TNP-modified syngeneic T 
cells (Figs 1, 3). Using t hese puri fied responder T-cell popula-
tion s we were able to demonstrate t hat EC can induce the 
generation of a lloreactive as well as TNP-self CTL in pr imary 
CML cult ures in t he absence of sp lenic !a-positive accessory 
cells. S ince pretreatment of t he E C by an t i-Ia plus C' com-
p letely abolished t heir stimulatory capacity, our results indicate 
t hat t he !a-bearing EC, p resumably dendri t ic LC, are t he crucial 
cell type in t his mechanism. Our findings add a particula rly 
sign ifican t facet to t he spectrum of in vit ro LC functions in 
t hat t hey provide evidence suggesting t hat sensit izing signa ls 
delivered a fter an t igenic exposure of the skin can originate in 
t he epidermis and can t rigger effector mechanisms leading to 
EC destruction . 
Alt hough our results clearly demonstrate t he crucial role of 
LC fo r the occurrence of EC-induced CTL, the mechanisms by 
w hich LC accomplish this task has still to be clarified . W hen 
on e assumes t hat t he role of LC in EC- induced gen eration of 
CTL is t hat of an t igen presen tation , severa l pathways appear 
conceivable . F irstly, LC may presen t LC-int rinsic class I al-
loan t igen s or haptens in conjunction with t he ir ! -region prod-
ucts, t hereby reducing t he role of sur rounding keratinocytes to 
t he delivery of an t igen nonspecific Interleukin I- like enhancing 
signals [20,21) . This possibility, that keratinocyte-bound ant i-
genic determinants do not contr ibute to t he generation of EC-
induced CTL, is sup ported by t he addit ional observation t hat 
LC-depleted , a nt i- Ia p lus C' -treated EC fa iled to stimulate t he 
gene ration of CTL in unfractionated a llogeneic SC responders 
a lt hough t he presence of accessory cells in t he responde r pop-
ulation should have sufficed to a llow CTL generation (Fig 2). 
F urther, in preliminary experimen ts in which purified splenic 
T cells were cocul tured wit h both an ti -Ia p lus C' -treated a llo-
geneic EC and unt reated EC syngeneic to the responder, we 
d id not detect CTL generation . T his m ay indicate t hat LC d id 
not fulfill true accessory cell fu nction [5,6]. Alternatively, one 
cannot exclude the possibili ty t hat a possible accesso ry cell 
fu nction of LC a nd t hat of splenic accessory cells might some-
how be obscured by inhibiti ng factors der ived from keratino-
cytes. T he elucidation of t his question will depend upon the 
availability of pure LC population s. 
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